JIA, Today and Tomorrow

Wenbo Zhang^{1

2}, Huihua Yuan³, Xing Lv³, Chunlin Huang⁴, Haisheng Zeng⁵, Dexin Liu⁶, Nicola Ruperto⁷, Huasong Zeng^{1

8

9}

Affiliations

¹ The Joint Center for Infection and Immunity, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
² The Joint Center for Infection and Immunity, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.
³ Department of Pediatric Rheumatology, Dongguan Maternal and Child Health Hospital, Dongguan, China.
⁴ Department of Immunology & Rheumatology, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
⁵ Department of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan Maternal and Child Health Hospital, Guangdong Medical University, Dongguan, Guangdong, China.
⁶ Department of Pediatric, Allergy Immune & Rheumatology, Liuzhou Hospital, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, National Children's Medical Center for Central and South China Region, Liuzhou, China.
⁷ IRCCS Istituto Giannina Gaslini, UOC Gaslini Trial Centre/Servizio di Sperimentazioni Cliniche Pediatriche/PRINTO, Genova, Italy.
⁸ Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
⁹ Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.

Editorial

Wenbo Zhang et al. Int J Rheum Dis. 2024 Dec.

. 2024 Dec;27(12):e70002.

doi: 10.1111/1756-185X.70002.

Wenbo Zhang^{1

2}, Huihua Yuan³, Xing Lv³, Chunlin Huang⁴, Haisheng Zeng⁵, Dexin Liu⁶, Nicola Ruperto⁷, Huasong Zeng^{1

8

9}

¹ The Joint Center for Infection and Immunity, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
² The Joint Center for Infection and Immunity, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.
³ Department of Pediatric Rheumatology, Dongguan Maternal and Child Health Hospital, Dongguan, China.
⁴ Department of Immunology & Rheumatology, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
⁵ Department of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan Maternal and Child Health Hospital, Guangdong Medical University, Dongguan, Guangdong, China.
⁶ Department of Pediatric, Allergy Immune & Rheumatology, Liuzhou Hospital, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, National Children's Medical Center for Central and South China Region, Liuzhou, China.
⁷ IRCCS Istituto Giannina Gaslini, UOC Gaslini Trial Centre/Servizio di Sperimentazioni Cliniche Pediatriche/PRINTO, Genova, Italy.
⁸ Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
⁹ Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.

No abstract available

References

1. A. Martini, D. J. Lovell, S. Albani, et al., “Juvenile Idiopathic Arthritis,” Nature Reviews. Disease Primers 8, no. 1 (2022): 5.
1. C. Hinze, F. Gohar, and D. Foell, “Management of Juvenile Idiopathic Arthritis: Hitting the Target,” Nature Reviews Rheumatology 11, no. 5 (2015): 290–300.
1. S. Ringold, S. T. Angeles‐Han, T. Beukelman, et al., “2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐systemic Polyarthritis, Sacroiliitis, and Enthesitis,” Arthritis & Rhematology 71, no. 6 (2019): 846–863.
1. K. B. Onel, D. B. Horton, D. J. Lovell, et al., “2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis,” Arthritis & Rhematology 74, no. 4 (2022): 553–569.
1. N. Ruperto, H. I. Brunner, P. Quartier, et al., “Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis,” New England Journal of Medicine 367 (2012): 2396–2406.